Guardant Health, Inc. (Nasdaq: GH), a leading precision oncology company, today announced that on February 11, 2025, the ...

Guardant Health (NASDAQ:GH – Get Free Report) had its target price upped by Piper Sandler from $34.00 to $50.00 in a report ...

We recently published a list of 10 Best Performing Mid Cap Stocks to Buy According to Analysts. In this article, we are going ...

Guardant Health (NASDAQ:GH – Get Free Report) had its target price boosted by research analysts at The Goldman Sachs Group ...

Piper Sandler analyst David Westenberg raised the firm’s price target on Guardant Health (GH) to $50 from $34 following quarterly results. The ...

Scotiabank raised the firm’s price target on Guardant Health (GH) to $52 from $47 and keeps an Outperform rating on the shares. Guardant Health ...

Fear and anxiety may be the key reasons why patients are choosing not to undergo screenings for colorectal cancer. A study conducted by the Harris Poll and Palo Alto, Calif-based Guardant Health asked ...

Globant S.A. , a digitally native technology services company (the "Company"), announced today that it filed its annual report on Form 20-F for the year ended December 31, 2024 (the "2024 Annual ...

In this article, we are going to take a look at where Guardant Health, Inc. (NASDAQ:GH) stands against other best performing mid cap stocks to buy according to analysts. On February 7, Simeon ...

Bill Abbott, President & CEO of Great American Media, joined industry leaders at the NRB 2025 International Christian Media ...

Researchers conduct a retrospective, population-based cohort study of adult patients with metastatic breast cancer who underwent genomic profiling at academic institutions.